takeda pharmaceutical co ltd
Transactions by TAKEDA PHARMACEUTICAL CO LTD (4502) in the last 6 months
Medical Tribune Inc. acquired Nippon-Rinshosha Limited from Takeda Pharmaceutical Company Limited (TSE:4502) on September 2, 2014. As per the terms of the contract, Nippon-Rinshosha Limited will continue its current medical book publishing business activities as a company within the Medical Tribune group.
Takeda Ireland Ltd announced that it has received €300 million in a round of funding from existing investor, Takeda Pharmaceutical Company Limited on May 11, 2014. The company issued common shares in the transaction. The company reported revenue of €114 million and loss of €150 million for the year ending March 31, 2013.
Sumika Chemical Analysis Service, Ltd. acquired Takeda Analytical Research Laboratories Ltd. from Takeda Pharmaceutical Company Limited (TSE:4502) on March 31, 2014.
|Abbott Laboratories||$42.90 USD||+0.18|
|Astellas Pharma Inc||¥1,591 JPY||0.00|
|Baxter International Inc||$74.99 USD||+0.44|
|Becton Dickinson and Co||$114.29 USD||+0.23|
|Bristol-Myers Squibb Co||$51.15 USD||+1.20|
|View Industry Companies|